Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis (HERICA)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Grupo de Estudo da Doença Inflamatória Intestinal
ClinicalTrials.gov Identifier:
NCT01408810
First received: July 20, 2011
Last updated: December 17, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)